These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34758928)

  • 21. Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae.
    Rice CA; Colon BL; Chen E; Hull MV; Kyle DE
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008353. PubMed ID: 32970675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic nanoparticle-conjugated bisindoles and hydrazinyl arylthiazole as novel antiamoebic agents against brain-eating amoebae.
    Kanwal ; Mungroo MR; Anwar A; Ali F; Khan S; Abdullah MA; Siddiqui R; Khan KM; Khan NA
    Exp Parasitol; 2020 Nov; 218():107979. PubMed ID: 32866583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repurposing of Drugs Is a Viable Approach to Develop Therapeutic Strategies against Central Nervous System Related Pathogenic Amoebae.
    Anwar A; Khan NA; Siddiqui R
    ACS Chem Neurosci; 2020 Aug; 11(16):2378-2384. PubMed ID: 32073257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infections with free-living amebae.
    Visvesvara GS
    Handb Clin Neurol; 2013; 114():153-68. PubMed ID: 23829906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain-Eating Amoebae: Predilection Sites in the Brain and Disease Outcome.
    Ong TYY; Khan NA; Siddiqui R
    J Clin Microbiol; 2017 Jul; 55(7):1989-1997. PubMed ID: 28404683
    [No Abstract]   [Full Text] [Related]  

  • 26. Lectins as virulence factors in
    Guzmán-Téllez P; Martínez-Castillo M; Flores-Huerta N; Rosales-Morgan G; Pacheco-Yépez J; la Garza M; Serrano-Luna J; Shibayama M
    Future Microbiol; 2020 Jul; 15():919-936. PubMed ID: 32716210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presence of potentially pathogenic free-living amoebae strains from well water samples in Guinea-Bissau.
    Baquero RA; Reyes-Batlle M; Nicola GG; Martín-Navarro CM; López-Arencibia A; Guillermo Esteban J; Valladares B; Martínez-Carretero E; Piñero JE; Lorenzo-Morales J
    Pathog Glob Health; 2014 Jun; 108(4):206-11. PubMed ID: 24934796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Balamuthia mandrillaris and anti-Naegleria fowleri effects of drugs conjugated with various nanostructures.
    Siddiqui R; Boghossian A; Alqassim SS; Kawish M; Gul J; Jabri T; Shah MR; Khan NA
    Arch Microbiol; 2023 Apr; 205(5):170. PubMed ID: 37017767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals.
    Schuster FL; Visvesvara GS
    Int J Parasitol; 2004 Aug; 34(9):1001-27. PubMed ID: 15313128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The transcriptome of Balamuthia mandrillaris trophozoites for structure-guided drug design.
    Phan IQ; Rice CA; Craig J; Noorai RE; McDonald JR; Subramanian S; Tillery L; Barrett LK; Shankar V; Morris JC; Van Voorhis WC; Kyle DE; Myler PJ
    Sci Rep; 2021 Nov; 11(1):21664. PubMed ID: 34737367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri.
    Schuster FL; Guglielmo BJ; Visvesvara GS
    J Eukaryot Microbiol; 2006; 53(2):121-6. PubMed ID: 16579814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular identification of waterborne free living amoebae (Acanthamoeba, Naegleria and Vermamoeba) isolated from municipal drinking water and environmental sources, Semnan province, north half of Iran.
    Javanmard E; Niyyati M; Lorenzo-Morales J; Lasjerdi Z; Behniafar H; Mirjalali H
    Exp Parasitol; 2017 Dec; 183():240-244. PubMed ID: 28916458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A year long study of the presence of free living amoeba in Spain.
    Magnet A; Fenoy S; Galván AL; Izquierdo F; Rueda C; Fernandez Vadillo C; Del Aguila C
    Water Res; 2013 Dec; 47(19):6966-72. PubMed ID: 24200005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum antibodies to Balamuthia mandrillaris, a free-living amoeba recently demonstrated to cause granulomatous amoebic encephalitis.
    Huang ZH; Ferrante A; Carter RF
    J Infect Dis; 1999 May; 179(5):1305-8. PubMed ID: 10191243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opportunistic amoebae: challenges in prophylaxis and treatment.
    Schuster FL; Visvesvara GS
    Drug Resist Updat; 2004 Feb; 7(1):41-51. PubMed ID: 15072770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Future Priorities in Tackling Infections Due to Brain-Eating Amoebae.
    Khan NA; Anwar A; Siddiqui R
    ACS Chem Neurosci; 2017 Nov; 8(11):2355. PubMed ID: 28933530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acanthamoeba spp. and Balamuthia mandrillaris leading to fatal granulomatous amebic encephalitis.
    Lee DC; Fiester SE; Madeline LA; Fulcher JW; Ward ME; Schammel CM; Hakimi RK
    Forensic Sci Med Pathol; 2020 Mar; 16(1):171-176. PubMed ID: 31773473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulomatous amoebic encephalitis: ghost response of an immunocompromised host?
    Baig AM
    J Med Microbiol; 2014 Dec; 63(Pt 12):1763-1766. PubMed ID: 25239626
    [No Abstract]   [Full Text] [Related]  

  • 39. Free-living amoebae isolated in the Central African Republic: epidemiological and molecular aspects.
    Farra A; Bekondi C; Tricou V; Mbecko JR; Talarmin A
    Pan Afr Med J; 2017; 26():57. PubMed ID: 28451034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular confirmation of Sappinia pedata as a causative agent of amoebic encephalitis.
    Qvarnstrom Y; da Silva AJ; Schuster FL; Gelman BB; Visvesvara GS
    J Infect Dis; 2009 Apr; 199(8):1139-42. PubMed ID: 19302010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.